|
EP0068838B1
(en)
|
1981-06-26 |
1986-09-17 |
The Upjohn Company |
Analgesic process and composition
|
|
US4389393A
(en)
|
1982-03-26 |
1983-06-21 |
Forest Laboratories, Inc. |
Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
|
|
US4404208A
(en)
|
1982-06-30 |
1983-09-13 |
E. I. Du Pont De Nemours And Company |
Analgesic mixture of nalbuphine and tiflamizole
|
|
US4612008A
(en)
|
1983-05-11 |
1986-09-16 |
Alza Corporation |
Osmotic device with dual thermodynamic activity
|
|
US4765989A
(en)
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
|
US4783337A
(en)
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
|
DE3665538D1
(en)
|
1985-01-23 |
1989-10-19 |
Asta Pharma Ag |
Synergistic combination of flupirtin and non-steroidal anti-phlogistics
|
|
ES2098264T3
(es)
|
1989-05-22 |
1997-05-01 |
Biochemical Veterinary Res |
Sales metalicas divalentes de indometacina.
|
|
US5708035A
(en)
*
|
1991-02-04 |
1998-01-13 |
Sepracor Inc. |
Methods of use and compositions of R(-) fluoxetine
|
|
AU662160B2
(en)
|
1991-07-04 |
1995-08-24 |
Taisho Pharmaceutical Co., Ltd. |
Analgesic
|
|
JPH05221857A
(ja)
|
1992-02-14 |
1993-08-31 |
Arakusu:Kk |
配合解熱鎮痛剤
|
|
US5472711A
(en)
|
1992-07-30 |
1995-12-05 |
Edward Mendell Co., Inc. |
Agglomerated hydrophilic complexes with multi-phasic release characteristics
|
|
US5330761A
(en)
|
1993-01-29 |
1994-07-19 |
Edward Mendell Co. Inc. |
Bioadhesive tablet for non-systemic use products
|
|
EP0702681A1
(en)
|
1993-06-07 |
1996-03-27 |
Merck & Co. Inc. |
Spiro-substituted azacycles as neurokinin antagonists
|
|
US5455046A
(en)
|
1993-09-09 |
1995-10-03 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
|
US5399362A
(en)
|
1994-04-25 |
1995-03-21 |
Edward Mendell Co., Inc. |
Once-a-day metoprolol oral dosage form
|
|
US20030056896A1
(en)
|
1995-05-12 |
2003-03-27 |
Frank Jao |
Effective therapy for epilepsies
|
|
US5914129A
(en)
|
1996-07-23 |
1999-06-22 |
Mauskop; Alexander |
Analgesic composition for treatment of migraine headaches
|
|
RS49982B
(sr)
|
1997-09-17 |
2008-09-29 |
Euro-Celtique S.A., |
Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
|
|
EA004032B1
(ru)
|
1998-09-10 |
2003-12-25 |
Нюкомед Данмарк А/С |
Фармацевтические композиции лекарственных веществ с быстрым высвобождением
|
|
ES2194536T3
(es)
|
1998-11-13 |
2003-11-16 |
Lilly Co Eli |
Combinacion de duloxetina con farmacos antiinflamatorios no esteroideos.
|
|
US6117900A
(en)
|
1999-09-27 |
2000-09-12 |
Asta Medica Aktiengesellschaft |
Use of retigabine for the treatment of neuropathic pain
|
|
WO2002026714A1
(en)
|
2000-09-27 |
2002-04-04 |
Takeda Chemical Industries, Ltd. |
Spiro compounds
|
|
EP1219304B1
(de)
|
2000-12-28 |
2004-10-20 |
Fresenius Kabi Austria GmbH |
Stabile Infusionslösung von Diclofenac-Salzen, deren Herstellung und Verwendung
|
|
EP1470126A1
(en)
|
2002-01-28 |
2004-10-27 |
Pfizer Inc. |
N-substituted spiropiperidine compounds as ligands for orl-1 receptor
|
|
ATE359827T1
(de)
|
2002-06-17 |
2007-05-15 |
Chiesi Farma Spa |
Prozess für die vorbereitung von piroxicam: beta- cyclodextrin einschlusskomplexe
|
|
US8637512B2
(en)
|
2002-07-29 |
2014-01-28 |
Glaxo Group Limited |
Formulations and method of treatment
|
|
DE10252667A1
(de)
*
|
2002-11-11 |
2004-05-27 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
MXPA05005611A
(es)
|
2002-11-26 |
2005-07-27 |
Alexza Pharmaceuticals Inc |
Uso de loxapina y amoxapina para la fabricacion de un medicamento para el tratamiento del dolor.
|
|
DE10257824B4
(de)
|
2002-12-10 |
2004-11-11 |
Kochem, Hans-Günter, Dr. |
Zusammensetzung zur Schmerzbehandlung, insbesondere zur Behandlung von Gelenkschmerzen
|
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
|
US7132452B2
(en)
|
2003-03-10 |
2006-11-07 |
Fang-Yu Lee |
Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
|
|
US20040222123A1
(en)
|
2003-05-06 |
2004-11-11 |
Barr Laboratories, Inc. |
Kit for pharmaceuticals
|
|
CN1245379C
(zh)
|
2003-10-30 |
2006-03-15 |
曹桂东 |
加巴喷丁的制法
|
|
DE10360792A1
(de)
|
2003-12-23 |
2005-07-28 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
BRPI0511941A
(pt)
|
2004-06-09 |
2008-01-22 |
Pfizer |
uso de (s, s)-reboxetina ou reboxetina racêmica
|
|
GB0412878D0
(en)
*
|
2004-06-09 |
2004-07-14 |
Pfizer Ltd |
Use
|
|
AU2006257274A1
(en)
|
2005-06-17 |
2006-12-21 |
Pfizer Inc. |
Alpha-(aryl-or heteroaryl-methyl)-beta piperidino propanamide compounds as ORL1-receptor antagonists
|
|
US8093408B2
(en)
*
|
2005-06-21 |
2012-01-10 |
The Company Wockhardt |
Antidepressant oral pharmaceutical compositions
|
|
CN101431990B
(zh)
|
2006-04-28 |
2011-08-03 |
格吕伦塔尔有限公司 |
包含3-（3-二甲基氨基-1-乙基-2-甲基-丙基）-酚和对乙酰氨基酚的药物结合
|
|
CN102675136B
(zh)
|
2006-04-28 |
2016-01-20 |
格吕伦塔尔有限公司 |
包含3-(3-二甲基氨基-1-乙基-2-甲基-丙基)-苯酚和nsaid的药物组合物
|
|
US20080014271A1
(en)
|
2006-07-13 |
2008-01-17 |
Ucb, S.A. |
Novel pharmaceutical compositions comprising levetiracetam
|
|
CN101147735A
(zh)
|
2006-09-19 |
2008-03-26 |
沈阳华泰药物研究有限公司 |
注射用药物组合物及其药盒
|
|
DE102006046745A1
(de)
|
2006-09-29 |
2008-04-03 |
Grünenthal GmbH |
Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
|
|
JP2008106028A
(ja)
|
2006-10-26 |
2008-05-08 |
Boehringer Ingelheim Internatl Gmbh |
慢性疼痛の治療におけるフリバンセリンの使用
|
|
DE102006056458A1
(de)
|
2006-11-28 |
2008-05-29 |
Grünenthal GmbH |
Arzneimittelzubereitung von Tramadol und Acetaminophen
|
|
US20080153874A1
(en)
|
2006-12-22 |
2008-06-26 |
Allergan Inc. |
Alpha-2b receptor agonist and anticonvulsant compositions for treating chronic pain
|
|
WO2008108639A1
(en)
|
2007-03-08 |
2008-09-12 |
Avantium Holding B.V. |
Co-crystalline forms of carbamazepine
|
|
EP1977744A1
(en)
|
2007-04-03 |
2008-10-08 |
Chemo Ibérica, S.A. |
Polymorphic Form alpha of (S)-Pregabalin and process for its preparation
|
|
US20100279984A1
(en)
|
2007-10-09 |
2010-11-04 |
Merck Patent Gmbh |
Pharmaceutical compositions containing benfotiamine and one or one more pharmaceutically active agents for the treatment of pain conditions of neuropathic origin
|
|
MX2010006608A
(es)
|
2007-12-21 |
2010-10-05 |
Paz Arzneimittelentwicklung |
Composiciones farmaceuticas y produccion y uso de las mismas en el tratamiento de neuropatias asociadas con el dolor.
|
|
EP2123626A1
(en)
|
2008-05-21 |
2009-11-25 |
Laboratorios del Dr. Esteve S.A. |
Co-crystals of duloxetine and co-crystal formers for the treatment of pain
|
|
EP2297092A1
(en)
|
2008-05-28 |
2011-03-23 |
Pliva Hrvatska D.O.O. |
Polymorphic and amorphous forms of lacosamide and amorphous compositions
|
|
CN100560061C
(zh)
|
2008-06-20 |
2009-11-18 |
海南锦瑞制药股份有限公司 |
一种氯诺昔康冻干粉针剂及其制备方法
|
|
EP2331087A1
(en)
|
2008-09-05 |
2011-06-15 |
Grünenthal GmbH |
Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3 diol and paracetamol
|
|
WO2010025931A2
(en)
|
2008-09-05 |
2010-03-11 |
Grünenthal GmbH |
Pharmaceutical combination
|
|
CA2735139A1
(en)
|
2008-09-05 |
2010-03-11 |
Petra Bloms-Funke |
Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol and an nsaid
|
|
DE102009013613A1
(de)
|
2009-03-17 |
2010-09-23 |
Ratiopharm Gmbh |
Trockenverarbeitung von Retigabin
|
|
KR101786818B1
(ko)
|
2010-07-30 |
2017-10-18 |
도레이 카부시키가이샤 |
신경장애성 동통의 치료제 또는 예방제
|
|
EP3459533A1
(en)
*
|
2010-08-04 |
2019-03-27 |
Grünenthal GmbH |
Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain
|
|
RU2589831C2
(ru)
*
|
2010-08-04 |
2016-07-10 |
Грюненталь Гмбх |
ЛЕКАРСТВЕННАЯ ДОЗИРОВАННАЯ ФОРМА, КОТОРАЯ СОДЕРЖИТ 6'-ФТОР-(N-МЕТИЛ- ИЛИ N, N-ДИМЕТИЛ-)-4-ФЕНИЛ-4', 9'-ДИГИДРО-3'Н-СПИРО[ЦИКЛОГЕКСАН-1, 1'-ПИРАНО[3, 4, b]ИНДОЛ]-4-АМИН
|
|
AR082559A1
(es)
*
|
2010-08-04 |
2012-12-19 |
Gruenenthal Gmbh |
Forma de dosificacion farmaceutica que comprende 6’-fluoro-(n-metil- o n,n-dimetil)-4’-fenil-4’,9’-dihidro-3’h-espiro[ciclohexan-1,1’-pirano[3,4,b]indol]-4-amina
|
|
US9320729B2
(en)
|
2012-05-18 |
2016-04-26 |
Gruenenthal Gmbh |
Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
|